BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36807337)

  • 1. Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women.
    Njoku K; Pierce A; Geary B; Campbell AE; Kelsall J; Reed R; Armit A; Da Sylva R; Zhang L; Agnew H; Baricevic-Jones I; Chiasserini D; Whetton AD; Crosbie EJ
    Br J Cancer; 2023 May; 128(9):1723-1732. PubMed ID: 36807337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery.
    Njoku K; Pierce A; Chiasserini D; Geary B; Campbell AE; Kelsall J; Reed R; Geifman N; Whetton AD; Crosbie EJ
    EBioMedicine; 2024 Apr; 102():105064. PubMed ID: 38513301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer.
    Njoku K; Barr CE; Sutton CJJ; Crosbie EJ
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Biomarker Panel for Early Detection of Lung Cancer Patients.
    Geary B; Walker MJ; Snow JT; Lee DCH; Pernemalm M; Maleki-Dizaji S; Azadbakht N; Apostolidou S; Barnes J; Krysiak P; Shah R; Booton R; Dive C; Crosbie PA; Whetton AD
    J Proteome Res; 2019 Sep; 18(9):3369-3382. PubMed ID: 31408348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.
    Liew PL; Huang RL; Wu TI; Liao CC; Chen CW; Su PH; Wang HC; Weng YC; Lai HC
    Clin Epigenetics; 2019 Nov; 11(1):170. PubMed ID: 31779688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
    Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
    Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
    Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
    Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Somatic Mutations in Urine Samples as a Noninvasive Method for the Detection and Molecular Classification of Endometrial Cancer.
    Costas L; Onieva I; Pelegrina B; Marin F; Carmona Á; López-Querol M; Frias-Gomez J; Peremiquel-Trillas P; Martínez JM; Dorca E; Brunet J; Pineda M; Ponce J; Matias-Guiu X; de Sanjosé S; Bosch FX; Alemany L; Paytubi S
    Clin Cancer Res; 2023 Sep; 29(18):3681-3690. PubMed ID: 37439797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.
    Mu AK; Lim BK; Aminudin N; Hashim OH; Shuib AS
    Arch Physiol Biochem; 2016 Jul; 122(3):111-6. PubMed ID: 26849673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer.
    Njoku K; Campbell AE; Geary B; MacKintosh ML; Derbyshire AE; Kitson SJ; Sivalingam VN; Pierce A; Whetton AD; Crosbie EJ
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in endometrial cancer protein biomarkers for use in the clinic.
    Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
    Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer's disease.
    Park SA; Jung JM; Park JS; Lee JH; Park B; Kim HJ; Park JH; Chae WS; Jeong JH; Choi SH; Baek JH
    Sci Rep; 2020 May; 10(1):7423. PubMed ID: 32366888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic prediction of endometrial cancer.
    Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
    Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
    Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
    Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
    van den Helder R; Wever BMM; van Trommel NE; van Splunter AP; Mom CH; Kasius JC; Bleeker MCG; Steenbergen RDM
    Clin Epigenetics; 2020 Nov; 12(1):165. PubMed ID: 33143739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate serum biomarkers of childhood-onset growth hormone deficiency using SWATH-MS and feature selection.
    Ortea I; Ruiz-Sánchez I; Cañete R; Caballero-Villarraso J; Cañete MD
    J Proteomics; 2018 Mar; 175():105-113. PubMed ID: 29317355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.
    Yurkovetsky Z; Ta'asan S; Skates S; Rand A; Lomakin A; Linkov F; Marrangoni A; Velikokhatnaya L; Winans M; Gorelik E; Maxwell GL; Lu K; Lokshin A
    Gynecol Oncol; 2007 Oct; 107(1):58-65. PubMed ID: 17659325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples.
    O'Flynn H; Ryan NAJ; Narine N; Shelton D; Rana D; Crosbie EJ
    Nat Commun; 2021 Feb; 12(1):952. PubMed ID: 33574259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.